A 45-minute panel discussion on recent findings of gadolinium deposition in patients who have undergone contrast-enhanced MRI. Being held May 21 at noon in the Grand Ballroom, as part of the America Society of Neuroradiology annual meeting.
Gadolinum Deposition and the Safety of MRI Contrast Agents
May 20th, 2016Dec 31st, 1969
Latest in Home
LLMs perform well on Japanese radiology board exam
September 15, 2025
CCTA reveals that CAD can occur in the absence of typical risk factors
September 15, 2025
Neuroinflammation persists for 2 years in long COVID
September 12, 2025